Publication for BLK and CCR6

Species	Symbol	Function*	Entrez Gene ID*	Other ID	Gene coexpression	CoexViewer
hsa	BLK	BLK proto-oncogene, Src family tyrosine kinase	640			[link]
hsa	CCR6	C-C motif chemokine receptor 6	1235

Pubmed ID	Priority	Text
28555384	0.97	CCR6, CCL21, IL2RA, and CD28 are associated with ACPA+ RA susceptibility but not with ACPA- RA, whilst markers at TNFAIP3, C5orf30, STAT4, ANKRD55, BLK, and PTPN22 are associated with both serotypes.
29377892	0.95	BLK, LINGO3, CCR6, P2RY10, RHOH, JUP, KRT14, PLA2G3, SPRR1A, KRT78, SFN, CLDN4, IL1RN, PKP3, CBLC, KRT16, TMEM79, KLK8, LYPD3 and LYPD5) were treated as valuable factors involved in the immune response and tumor cell development in tumorigenesis.
21980439	0.92	CCR6, REL, SPRED2, BLK, FAM107A, and IL2RA).
22355377	0.82	CCR6, BLK, CD40 and IL2RB.
26997879	0.81	BLK, BANK1, CD247, PTPN22, IL23R, CD226, PLD4, and TLR2, and the inflammatory genes, including IL1A, interleukin-1 receptor-associated kinase 1 (IRAK1), interferon regulatory factor 5 (IRF5), TNFAIP3, CTGF, CXCL8, and CCR6.
23028528	0.68	BLK, FYN, ICSBP1, BCL11A, VAV3, CD1C, CD37, CCR6, BCL6 and CD22.
20059468	0.62	CCR6, TRAF5, and B lymphoid tyrosine kinase (BLK) may play a role in suppressing a lymphocyte response in conjunction with the observed decreases in antigen processing and presentation as well as IL-16 (see Figure 3A).